BioMavericks

BioMavericks is an early-stage biotechnology company developing an AI-driven liquid biopsy platform for the early detection of cancer.

Its lead product targets the discovery and validation of blood-based biomarkers for early-stage pancreatic cancer diagnostics, integrating molecular cell biology, multi-omics data analysis, and machine learning.

The company has received grants and awards from Innovate UK, the Greater London Authority, and MedCity, and has participated in the Discovery Park innovation programme.